FI852990L - Saosom antiarytmiska aemnen anvaendbara 2,5-pyrrolidindionderivat. - Google Patents

Saosom antiarytmiska aemnen anvaendbara 2,5-pyrrolidindionderivat.

Info

Publication number
FI852990L
FI852990L FI852990A FI852990A FI852990L FI 852990 L FI852990 L FI 852990L FI 852990 A FI852990 A FI 852990A FI 852990 A FI852990 A FI 852990A FI 852990 L FI852990 L FI 852990L
Authority
FI
Finland
Prior art keywords
pyrrolidindionderivat
antiarytmiska
aemnen
saosom
anvaendbara
Prior art date
Application number
FI852990A
Other languages
English (en)
Other versions
FI80876C (fi
FI80876B (fi
FI852990A0 (fi
Inventor
Bipinchandra Nanubhai Desai
Robert John Chorvat
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of FI852990A0 publication Critical patent/FI852990A0/fi
Publication of FI852990L publication Critical patent/FI852990L/fi
Application granted granted Critical
Publication of FI80876B publication Critical patent/FI80876B/fi
Publication of FI80876C publication Critical patent/FI80876C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Materials For Photolithography (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Lubricants (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Professional, Industrial, Or Sporting Protective Garments (AREA)
  • Suspension Of Electric Lines Or Cables (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI852990A 1984-08-03 1985-08-02 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 2,5-pyrrolidindionderivat. FI80876C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/637,633 US4554353A (en) 1984-08-03 1984-08-03 2,5-Pyrrolidinedione derivatives useful as antiarrhythmic agents
US63763384 1984-08-03

Publications (4)

Publication Number Publication Date
FI852990A0 FI852990A0 (fi) 1985-08-02
FI852990L true FI852990L (fi) 1986-02-04
FI80876B FI80876B (fi) 1990-04-30
FI80876C FI80876C (fi) 1990-08-10

Family

ID=24556766

Family Applications (1)

Application Number Title Priority Date Filing Date
FI852990A FI80876C (fi) 1984-08-03 1985-08-02 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 2,5-pyrrolidindionderivat.

Country Status (18)

Country Link
US (1) US4554353A (fi)
EP (1) EP0170281B1 (fi)
JP (1) JPS6143164A (fi)
AT (1) ATE53575T1 (fi)
AU (1) AU581914B2 (fi)
CA (1) CA1270833A (fi)
DE (1) DE3578172D1 (fi)
DK (1) DK163661C (fi)
ES (1) ES8703421A1 (fi)
FI (1) FI80876C (fi)
GR (1) GR851890B (fi)
IE (1) IE60110B1 (fi)
IL (1) IL75985A (fi)
NO (1) NO166529C (fi)
NZ (1) NZ212955A (fi)
PH (1) PH20948A (fi)
PT (1) PT80905B (fi)
ZA (1) ZA855860B (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD973876S1 (en) * 2020-03-18 2022-12-27 Stephen A. Young Blood sampling device

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH306905A (de) * 1951-09-11 1955-04-30 Ciba Geigy Verfahren zur Herstellung eines neuen Dioxopyrrolidins.
US2666060A (en) * 1951-09-11 1954-01-12 Ciba Pharm Prod Inc 1, 3-bisaminoalkyl-3-phenyl-2, 5-dioxopyrrolidines
FR1079802A (fr) * 1952-02-26 1954-12-02 Parke Davis & Co Fabrication de dérivés de la succinimide

Also Published As

Publication number Publication date
IE851932L (en) 1986-02-03
PH20948A (en) 1987-06-10
FI80876C (fi) 1990-08-10
IE60110B1 (en) 1994-06-01
ATE53575T1 (de) 1990-06-15
DK163661C (da) 1992-08-24
PT80905A (en) 1985-09-01
PT80905B (pt) 1987-09-30
CA1270833C (en) 1990-06-26
EP0170281A2 (en) 1986-02-05
NO166529C (no) 1991-08-07
AU581914B2 (en) 1989-03-09
IL75985A (en) 1988-07-31
ZA855860B (en) 1986-10-29
ES545870A0 (es) 1987-02-16
DK353785A (da) 1986-02-04
NZ212955A (en) 1988-03-30
EP0170281B1 (en) 1990-06-13
DE3578172D1 (de) 1990-07-19
JPH0566942B2 (fi) 1993-09-22
JPS6143164A (ja) 1986-03-01
FI80876B (fi) 1990-04-30
US4554353A (en) 1985-11-19
IL75985A0 (en) 1985-12-31
ES8703421A1 (es) 1987-02-16
NO166529B (no) 1991-04-29
FI852990A0 (fi) 1985-08-02
AU4569385A (en) 1986-02-06
CA1270833A (en) 1990-06-26
EP0170281A3 (en) 1986-06-25
GR851890B (fi) 1985-12-09
DK163661B (da) 1992-03-23
NO853069L (no) 1986-02-04
DK353785D0 (da) 1985-08-02

Similar Documents

Publication Publication Date Title
ES2070660B1 (es) Un procedimiento para la preparacion de 2,5-damino-3-hidroxihexanos sustituidos, utiles como inhibidores de proteasas retrovirales.
CA2009735A1 (en) Insecticidally active nitro compounds
NO163331C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 6,7-disubstituerte 1-cyklopropyl-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyrer.
IT1212143B (it) Composizione ad attivita'tricogena.
GB8720910D0 (en) Antiarrhythmic agents
ATE41773T1 (de) 4,5-dihydro-4-oxo-2((2-transphenylcyclopropyl)amino>-3-furancarbonsaeuren und derivate davon.
EG17752A (en) Benzoylurea derivatives
EP0470431A3 (en) Use of phosphomycin and the pharmaceutically acceptable salts thereof as a topical cicatrizer
FI852990L (fi) Saosom antiarytmiska aemnen anvaendbara 2,5-pyrrolidindionderivat.
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
TR23271A (tr) En asagi % 95.5 safliginda p-ksilol'un kazanilmasina mahsus usul
ES8708132A1 (es) Procedimiento para preparar n-fenil-4-fenil-1-piperazincarboxamidinas y compuestos afines como agentes anti-arritmicos
ES2001042A6 (es) Un metodo para la preparacion de acidos 5,6-dialcoxiantranilicos
MY104318A (en) Novel thiopen compounds and their preparation
RO94553A (ro) Compozitie insecticida
SU1319521A1 (ru) 5-(2,2,2-Трифтор-1-окси-1-трифторметилэтил)фурил-2-метилгидразонийбромид, проявляющий антимикробную и противовоспалительную активность
YU47871B (sh) Derivati aminokiselina
SU1455625A1 (ru) 1-(1,3-диметилксантинил-8-тио)-3-морфолинопропанол-2, проявляющий гипотензивную и противоаритмическую активность
SU1617908A1 (ru) β-ДИЭТИЛАМИНОЭТИЛОВЫЙ ЭФИР 2,4-ДИМЕТИЛПИРАЗОЛО[1,5-а]БЕНЗИМИДАЗОЛИЛ-3-КАРБОНОВОЙ КИСЛОТЫ ГИДРОХЛОРИД, ОБЛАДАЮЩИЙ АНТИАРИТМИЧЕСКОЙ АКТИВНОСТЬЮ
SU1221874A1 (ru) 1,1-Этилиденди-(5-нитро-2-фуроиламин), проявляющий противомикробную и противовоспалительную активность
IT8419056A0 (it) Procedimento per l'isolamento di l-amminoacidi.
SU1302661A1 (ru) 3-(3,5-Диметилпиразолил-1)-6-(2-карбэтокси-1-метилэтилиден-1)гидразинопиридазин, обладающий противовоспалительной и противомикробной активностью

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: G.D. SEARLE & CO.